Paper2934816
A blood vessel model constructed from collagen and cultured vascular cells.
Weinberg CB and 1 other. Science, 1986. Cited by 763 papers, by iCite.
Cite this record
ConductScience Library. A blood vessel model constructed from collagen and cultured vascular cells. Papers, record 2934816. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2934816
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Vessels | Major topic |
| Collagen | Major topic |
| Models, Cardiovascular | Major topic |
| Animals | |
| Aorta | |
| Cattle | |
| Cells, Cultured | |
| Endothelium | |
| Microscopy, Electron, Scanning | |
| Muscle, Smooth, Vascular | |
| Polyethylene Terephthalates |
Source PubMed
Cited by272
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 763 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42938961 | Mechanical Discontinuity and Mechanobiology at the Graft-Host Junction: Enhancing Functional Integration in Soft-Tissue Implantation. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42938961 | PubMed |
| 42733867 | A one-step volumetric biofabrication platform for complex hydrogel-based hollow biomaterials. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42733867 | PubMed |
| 42194346 | An IoT-Enabled Modular 3D Bioreactor for Vascular Tissue Engineering: Design, Fabrication, and Biological Validation. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42194346 | PubMed |
| 42072237 | Anterior Cruciate Ligament Tissue Engineering: Biological Principles, Engineered Substitutes, and Preclinical Outcomes. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42072237 | PubMed |
| 41524039 | Synthetic and Tissue-Engineered Vascular Grafts: Current Status, Emerging Technologies, and Clinical Prospects. | Rev Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41524039 | PubMed |
| 41090748 | Matrix-Guided Vascular-like Cord Formation by MRC-5 Lung Fibroblasts: Evidence of Structural and Transcriptional Plasticity. | Cells | 2025 | https://conductscience.org/library/papers/41090748 | PubMed |
| 40418233 | Artificial blood vessels-clinical development of TEVG. | J Artif Organs | 2025 | https://conductscience.org/library/papers/40418233 | PubMed |
| 40225752 | Harnessing the Regenerative Potential of Fetal Mesenchymal Stem Cells and Endothelial Colony-Forming Cells in the Biofabrication of Tissue-Engineered Vascular Grafts (TEVGs). | J Tissue Eng Regen Med | 2024 | https://conductscience.org/library/papers/40225752 | PubMed |
| 40213445 | Stem-Cell-Based Small-Diameter Blood Vessels with 3D Printing. | Small Sci | 2024 | https://conductscience.org/library/papers/40213445 | PubMed |
| 40188212 | Development and deployment of a functional 3D-bioprinted blood vessel. | Sci Rep | 2025 | https://conductscience.org/library/papers/40188212 | PubMed |
| 39763291 | Injury-on-a-chip for modelling microvascular trauma-induced coagulation. | Lab Chip | 2025 | https://conductscience.org/library/papers/39763291 | PubMed |
| 39555400 | Bioengineered human arterial equivalent and its applications from vascular graft to in vitro disease modeling. | iScience | 2024 | https://conductscience.org/library/papers/39555400 | PubMed |
| 39444940 | Recent research progresses of bioengineered biliary stents. | Mater Today Bio | 2024 | https://conductscience.org/library/papers/39444940 | PubMed |
| 39329689 | Mesenchymal Stem Cell-Conditioned Media-Loaded Microparticles Enhance Acute Patency in Silk-Based Vascular Grafts. | Bioengineering (Basel) | 2024 | https://conductscience.org/library/papers/39329689 | PubMed |
| 39211011 | Cardiac tissue engineering: an emerging approach to the treatment of heart failure. | Front Bioeng Biotechnol | 2024 | https://conductscience.org/library/papers/39211011 | PubMed |
| 39194760 | Two Decades of Advances and Limitations in Organ Recellularization. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/39194760 | PubMed |
| 39056818 | Biomimetic Approaches in Scaffold-Based Blood Vessel Tissue Engineering. | Biomimetics (Basel) | 2024 | https://conductscience.org/library/papers/39056818 | PubMed |
| 38982541 | Applications of extraembryonic tissue-derived cells in vascular tissue regeneration. | Stem Cell Res Ther | 2024 | https://conductscience.org/library/papers/38982541 | PubMed |
| 38920913 | Formation of Stable Vascular Networks by 3D Coaxial Printing and Schiff-Based Reaction. | Gels | 2024 | https://conductscience.org/library/papers/38920913 | PubMed |
| 38836460 | Vascular Damage and Repair - Are Small-Diameter Vascular Grafts Still the "Holy Grail" of Tissue Engineering? | Physiol Res | 2024 | https://conductscience.org/library/papers/38836460 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2934816
GET https://conductscience.org/api/papers/v1/2934816/cited_by?page=2